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Abstract 52 
Cross-sectional imaging of the heart utilizing computed tomography (CT) and 53 
magnetic resonance imaging (MRI) has been shown to be superior for the 54 
evaluation of cardiac morphology and systolic function in humans compared to 55 
echocardiography. The purpose of this prospective study was to test the effects of 56 
two different anesthetic protocols on cardiac measurements in 10 healthy beagle 57 
dogs using 64-multidetector row computed tomographic angiography (64-58 
MDCTA), 3T magnetic resonance (MRI) and standard awake echocardiography. 59 
Both anesthetic protocols used propofol for induction and isoflourane for anesthetic 60 
maintenance. In addition, protocol A used midazolam/fentanyl and protocol B used 61 
dexmedetomedine as premedication and constant rate infusion during the 62 
procedure. Significant elevations in systolic and mean blood pressure were 63 
present when using protocol B. There was overall good agreement between the 64 
variables of cardiac size and systolic function generated from the MDCTA and MRI 65 
exams and no significant difference was found when comparing the variables 66 
acquired using either anesthetic protocol within each modality. Systolic function 67 
variables generated using 64-MDCTA and 3T MRI were only able to predict the 68 
left ventricular end diastolic volume as measured during awake echocardiogram 69 
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when using protocol B and 64-MDCTA. For all other systolic function variables, 70 
prediction of awake echocardiographic results was not possible (P = 1). Planar 71 
variables acquired using MDCTA or MRI did not allow prediction of the 72 
corresponding measurements generated using echocardiography in the awake 73 
patients (P=1). Future studies are needed to validate this approach in a more 74 
varied population and clinically affected dogs.  75 
 76 
Introduction 77 
In companion animals the evaluation of cardiac morphology and systolic function 78 
has mainly been based on echocardiographic evaluation and cardiac 79 
catheterization.1-6 The potential role of MRI in the future of veterinary clinical 80 
cardiology has been reviewed critically24 and recent publications have utilized MRI 81 
and/or MDCT for functional and morphological cardiac evaluations15, 23, 25-29, 40, 41. 82 
Cross-sectional imaging of the heart utilizing computed tomography (CT) and 83 
magnetic resonance imaging (MRI) has shown to be superior for the evaluation of 84 
cardiac morphology and systolic function in humans compared to 85 
echocardiography.7-14 Apart from case reports describing congenital or neoplastic 86 
morphological abnormalities involving the heart or great vessels in companion 87 
animals15-22 these modalities have rarely been compared for their use in evaluation 88 
of cardiac function.23-29 While these cross-sectional exams are generally 89 
performed in the awake human patient,30 companion animal patients require 90 
anesthesia or heavy sedation at a minimum to undergo these studies. Although 91 
different anesthetic protocols have been used,23, 25, 27-29, 31 the effects of specific 92 
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anesthetic protocols on image quality, systolic function and cardiac morphologic 93 
variables as determined by cross-sectional imaging have not been systematically 94 
evaluated. Furthermore, to optimize image quality, a target heart rate of <65bpm 95 
is recommended for multidetector computed tomographic angiography (MDCTA) 96 
in people.32   The canine heart rate varies with many factors, including choice of 97 
anesthetic/sedative agents as well as body weight; however, rates between 80-98 
150 are commonly seen in awake patients.33 99 
 100 
The primary goal of this study was to analyze variables of cardiac morphology and 101 
systolic function using 64 MDCTA and magnetic resonance imaging (MRI) at 3 102 
Tesla by comparing two anesthetic protocols for heart rate control and impact on 103 
cardiac function in 10 healthy dogs. The secondary goal was to compare the 104 
variables of cardiac size and systolic function generated by MDCTA to MRI and to 105 
relate those to the current clinical practice of echocardiography in the awake dog.  106 
The results were intended to provide baseline recommendations for further cardiac 107 
investigations using MDCTA and MRI in dogs. The hypothesis for this study was 108 
that parameters acquired using CT and MRI with either anesthetic protocol would 109 
be comparable but differ from parameters acquired using echocardiography on the 110 
awake dogs.  111 
 112 
Material and Methods 113 
Animal preparation: The University of Wisconsin’s Institutional Animal Care and 114 
Use Committee approved all procedures. Ten purpose-bred healthy beagle dogs 115 
 6 
with a mean age of 10.4 (range 7-20) months and mean body weight of 10.7 (range 116 
8.9-12.7) kg were used in this study and underwent awake echocardiography once 117 
and then retrospectively EKG-gated MDCTA and MRI under anesthesia on two 118 
different days, using a different anesthetic protocol for each of the two anesthetic 119 
episodes. The order of MDCTA and MRI was randomized as well as the order of 120 
the anesthetic protocols for heart rate regulation for each dog.  121 
A 20G intravenous catheter was placed in the both the right and left cephalic veins; 122 
the left was used for anesthesia purposes and the right for contrast administration 123 
in all dogs. Anesthetic monitoring included modality specific recording of 124 
electrocardiography (using the footpads for the CT exam and the chest for the MRI 125 
exam for electrode placement) as well as pulse-oximetry to monitor heart rate, 126 
rhythm and hemoglobin saturation; systolic, diastolic and mean blood pressure 127 
was non-invasively monitored with a cardiac monitor (Cardell Veterinary Monitor, 128 
Model 9401, CAS Medical Systems, Branford, CT, 06405). Short periods of apnea 129 
were induced by mild hyperventilation and halting the mechanical ventilator when 130 
needed during image acquisition. 131 
Echocardiography: standard awake auscultation and echocardiographic exam 132 
(Vivid 7, GE Health Care, Waukashea, WI, USA, 8 and 5MHz transducers) was 133 
performed by a board certified veterinary cardiologist (RLS) once, prior to the 134 
anesthetic episodes for cross-sectional imaging. The following variables were 135 
recorded using M-mode: diastolic and systolic interventricular septal thickness 136 
(IVSd, IVSs), left ventricular internal diameter (LVIDd, LIVDs) and left ventricular 137 
posterior wall thickness (LVPWd, LVPWs). Additionally standard single plane 2D 138 
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B-mode images were used to acquire measurements of the aortic, left atrial and 139 
main pulmonary arterial diameter; left atrium to aorta ratio (LA/Ao ratio) and aorta 140 
to pulmonary artery (Ao/PA ratio) were calculated from those measurements. 141 
Fractional shortening (FS %) was calculated using the following formula: FS = 142 
(LVIDd – LVIDs)/LVIDd x 100. End diastolic volume (EDV), end systolic volume 143 
(ESV), ejection fraction (EF) and stroke volume (SV) were calculated using the 144 
Simpson method.34 Left ventricular mass was calculated from M-mode 145 
measurements using the following formula: LVM = 1.04 x [(LVIDd + LVWd + IVSd)3 146 
– (LVIDd)3] – 13.6g2.  147 
Anesthesia protocols: All dogs were induced using a propofol bolus to effect (2-6 148 
mg/kg) for each of the two cross-sectional imaging events. The animals were orally 149 
intubated, placed in dorsal recumbency in a custom made trough for positioning in 150 
CT and MRI and maintained on isoflurane (Vaporizer set at 1-2%) and 100% 151 
oxygen using mechanical ventilation to an end-tidal CO2 level between 35-152 
40mmHg. The dogs also received maintenance intravenous Lactated Ringer’s 153 
Solution (5-10 ml/kg/hr; Abbott Laboratories, North Chicago, IL, USA) through the 154 
left cephalic catheter. Protocol A used fentanyl (Fentanyl Citrate, West-ward, 155 
Eatontown, NJ, USA) 5μg/kg bolus for premedication followed by 10μg/kg/hr 156 
continuous rate infusion (CRI) and midazolam (Midazolam, Hospira, Inc., Lake 157 
Forest, IL, USA) 0.2mg/kg bolus followed by 0.2mg/kg/hr CRI. Protocol B used 158 
dexmedetomedine (Dexdomitor, Pfizer Animal Health, New York, New York, USA) 159 
1-2μg/kg bolus for premedication and 1-2μg/kg/hr CRI. 160 
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Cardiac MDCTA: Cardiac exams were performed using a 64-MDCT unit 161 
(Discovery CT750 HD, General Electrics Medical Systems, Waukesha, WI, USA). 162 
A transverse plane helical exam of the thorax was performed using 1.25mm slice 163 
thickness and reconstruction interval, medium frequency reconstruction kernel, 164 
80kVp, 200mA, 0.35s tube rotation time and a pitch of 0.51, followed by acquisition 165 
of a localizer image over the right ventricular outflow tract and the aortic root. Using 166 
the semi-automated bolus tracking function a retrospectively EKG-gated cardiac 167 
MDCTA was performed using 15ml iodinated contrast medium (Omnipaque 300, 168 
NovaPlus GE Healthcare, Princeton, NJ, USA) followed by a 5ml saline flush 169 
administered from a dual barrel injector at 2ml/s and 325PSI. Contrast injection 170 
was timed to mainly opacify the left atrium, left ventricle, coronary arteries and 171 
thoracic aorta. Scan parameters used for the retrospectively gated scan were set 172 
to 1.25mm slice thickness, 0.625mm spacing between slices, medium frequency 173 
reconstruction algorithm, DFOV 12cm centered over the heart, 80kVp, 400mA, 174 
0.35s tube rotation time and helical pitch of 0.24.  175 
Cardiac MRI: The exams were performed using a 3 Tesla MRI unit (Discovery 176 
MR750, GE Healthcare, Waukesha, WI, USA) using a 32-channel upper torso coil. 177 
Insulated EKG leads were placed on the chest wall, as placement of EKG leads 178 
on the footpads using non-insulated cables did not produce an EKG trace when 179 
the dogs were advanced into the magnet. Localizer scans were acquired in three 180 
planes. Then the following sequences were acquired: EKG-gated cine transverse 181 
plane, approximate three chamber, approximate four chamber, short axis cine 182 
balanced steady-state free precession (SSFP; TR 3.3-4.1ms, TE 45ms, 45 degree 183 
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flip angle, 224x224 matrix, FOV 230-310x184-207mm, pPOV 0.6-0.8, VPS 12-18, 184 
ETL 1, NEX 1, BW 125, 6mm slice thickness). 185 
After the last cross-sectional imaging modality per day was completed the animals 186 
were recovered; after the last episode the dogs were humanely euthanized 187 
according to institutional protocol requirements.  188 
 189 
Image analysis: Evaluation of the MDCTA and MRI studies was performed using 190 
semi-automated software (OsiriX 5.6 64-bit35 and ReportCARDTM 4.4.6, GE 191 
Healthcare, Waukesha, WI, USA, respectively) by a board certified veterinary 192 
radiologist (RD) under guidance of a human radiologist specialized in 193 
cardiovascular imaging (CJF). The exams were randomized for evaluation and 194 
the reviewer was blinded to the anesthetic protocol used for each study. Short 195 
axis, approximate three- and four-chamber views of the MDCTA images were 196 
generated at 1.25mm slice thickness using open source software35 to mirror the 197 
plane alignment generated in the MRI exams. All studies were inspected for 198 
diagnostic image quality to apply measurements by evaluating for adequate 199 
contrast, border definition and presence or absence of artifacts.  200 
Using the short axis planes, regions of interest were semi-automatically drawn 201 
along the endocardial and epicardial border on all images including the left 202 
ventricle from the apex to the level of the annulus; where slices with greater than 203 
25% of annulus in the imaging plane marked the basal border of the ventricle 204 
included in the evaluation. The papillary muscles were included in the ventricular 205 
volume for consistency (Figure 1). Using the transverse plane images, semi-206 
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automated regions of interest were also placed along the endocardial borders of 207 
the right ventricle, where the tricuspid and pulmonic annulus marked the borders 208 
of the ventricular volume included, also here the papillary muscles were included 209 
with the ventricular volume for consistency (Figure 2). This method was used to 210 
generate the following volumetric variables from the MDCTA and MRI exams 211 
respectively using the Simpson method:36 Left ventricular end diastolic and end 212 
systolic volume (LVEDV and LVESV); left ventricular end diastolic and end systolic 213 
epicardial volume (epiEDV and epiESV). Left ventricular stroke volume (LVSV = 214 
LVEDV - LVESV) and left ventricular ejection fraction (LVEF = LVSV / LVEDV) 215 
were calculated from these measurements. To verify alignment of the regions of 216 
interest drawn only 10% variability between the measurements for left ventricular 217 
end diastolic and end systolic myocardial mass (LVmassD and LVmassS) was 218 
allowed per dog within the same and between anesthetic episodes. Right 219 
ventricular diastolic volume (RVEDV) and right ventricular end systolic volume 220 
(RVESV) were recorded; right ventricular stroke volume (RVSV = RVEDV – 221 
RVESV) and right ventricular ejection fraction (RVEF = RVSV / RVESV) were 222 
calculated from these measurements.  223 
The following planar measurements were obtained: systolic and diastolic 224 
interventricular septal wall thickness (IVSs, IVSd) and left ventricular posterior wall 225 
thickness (LVPWs, LVPWd) thickness; left ventricular internal diameter (LVIDs, 226 
LVIDd), mitral and aortic annulus diameter, proximal aortic, proximal pulmonary 227 
artery and left atrial diameter.  228 
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The short axis view, corresponding to the right parasternal short axis view used in 229 
echocardiography, was used to measure the systolic and diastolic interventricular 230 
septal wall and left ventricular posterior wall thickness as well as the internal 231 
diameter of the left ventricle (Figure 3).   232 
Fractional shortening (FS %) was calculated from these values (FS = (LVIDd – 233 
LVIDs)/LVIDd x 100). 234 
The approximate three chamber view, corresponding to the parasternal long axis 235 
view used in echocardiography, was used to measure the end systolic left atrial 236 
diameter and aortic annulus diameter just prior to opening of the mitral valves and 237 
while the aortic valves were open as well as end diastolic mitral annulus diameter 238 
while the mitral valves were open (Figure 4 and 5). The left atrium/aorta ratio 239 
(La/Ao ratio) was calculated from these values (La/Ao = left atrial diameter/aortic 240 
annulus diameter). The approximate four chamber view, corresponding to the left 241 
apical four chamber view as used in echocardiography, was used for a repeat 242 
measurement of the mitral annulus (Figure 6). The transverse plane views, similar 243 
to the right parasternal short axis views in echocardiography, were used to 244 
measure the diameter of the proximal aorta and the main pulmonary artery (Figure 245 
7). The aorta/pulmonary artery ratio (Ao/Pa ratio) was calculated from these 246 
measurements (Ao/Pa = base of the aorta diameter/main pulmonary artery 247 
diameter). 248 
 249 
Statistical analysis: Open source software was used for statistical evaluation.37 For 250 
all variables evaluated summary statistics (quartiles, mean, standard deviation 251 
 12 
(SD), minimum and maximum) were computed by one observer (AMR). Medians 252 
and extremes were recorded.  253 
To establish baseline comparison of the two anesthetic protocols within each 254 
imaging modality (i.e. MDCTA and MRI) the data was compared with a paired 255 
Wilcoxon signed rank test. Significance was set at P ≤ 0.05. One test was done for 256 
MDCTA values and another for the MRI values. Within each type of measurement 257 
(i.e. individual variables to compare) the P-values were adjusted with a Holm-258 
Bonferroni step-down procedure.38  259 
To characterize the typical discrepancy between MDCTA and MRI when 260 
measuring the same cardiac attribute, Bland-Altman 95% limits of agreement 261 
analysis was used; bias (average difference), lower (LLOA) and upper level of 262 
agreement (ULOA) are reported. As both anesthesia protocols were pooled, 263 
possible correlation arising from the repeated measures needed to be allowed for, 264 
since each dog contributed two observations.39 265 
Lastly, the results for the left ventricular systolic function and planar variables 266 
generated using the cross-sectional modalities with each anesthetic protocol were 267 
compared to the comparable variables acquired using echocardiography using the 268 
Friedman rank sum test, pairwise comparisons were then generated using the 269 
Wilcoxon signed rank test. A simple linear regression was used to determine 270 
whether any of the anesthesia-by-imaging modality combinations could predict the 271 
values observed with echocardiography when the dogs were awake. The Holm-272 
Bonferroni step-down procedure was used to adjust the P-values for the 273 
significance of the slope variable.38  274 
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 275 
Results 276 
On awake auscultation, 2/10 dogs had an irregular cardiac rhythm and no murmurs 277 
were auscultated in any dog at an average heart rate of 115 ± 19bpm. One dog 278 
had a marked respiratory sinus arrhythmia during echocardiography; the 279 
remaining 9 dogs had a normal sinus rhythm. Echocardiographic examination 280 
showed a trivial amount of mitral regurgitation in one dogs and trace tricuspid 281 
insufficiency in one dog. Two dogs showed very mild left ventricular enlargement 282 
with normal function. Overall, no hemodynamically significant abnormalities were 283 
noted in any of the 10 dogs.  284 
Both anesthetic protocols provided adequate anesthesia of all dogs and recovery 285 
was uneventful in all cases. The median (minimum-maximum) heart rate with 286 
protocol A was 81.6 (68.6-96.0) bpm and 76.8 (66-98.6) bpm (P = 1) during the 287 
MDCTA and MRI exam respectively. Using protocol B, the median heart rate was 288 
73.3 (62.7-102.6) bpm and 71 (64.4-118.8) bpm (P = 1) during the MDCTA and 289 
MRI exam, respectively. In one dog the target heart rate of < 65bpm was 290 
consistently achieved using protocol B. Vital variables recorded during the CT and 291 
MRI exams using protocol A and B are summarized in detail in Table 1. Comparing 292 
protocol A and B, diastolic and mean blood pressure were significantly higher (P = 293 
0.033 and P = 0.012) and systolic blood pressure was marginally higher (P = 0.052) 294 
using protocol B. There was no significant difference found between the remaining 295 
recorded physiological values using either protocol (systolic blood pressure P = 296 
0.052, Co2 P = 0.075; Table 1). One dog experienced slight tachycardia 297 
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immediately following CT contrast medium administration but the heart rate 298 
spontaneously returned to pre-contrast levels within 10 minutes of administration. 299 
On average the duration of the MDCTA exam including set up of the dogs, 300 
acquisition of localizer images, pre contrast exam and retrospectively gated 301 
cardiac exam was 9.31 ± 0.17min; the duration of the retrospectively gated 302 
angiography itself lasted an average of 5.0 ± 0.68s. Average duration of the MRI 303 
exam including patient positioning, setup of anesthetic and gating equipment, 304 
acquisition of localizer images and the cardiac exam lasted for 51.0 ± 3.26min. In 305 
the first study dog, delays were encountered, mainly due to difficulties in obtaining 306 
an accurate EKG signal, which was remedied by switching to a different, insulated, 307 
EKG cable. Thus, this time was not accounted for in calculation of the average 308 
duration. The acquisition of the four plane SFFP sequences only took 19.21 ± 309 
7.58min. 310 
The smart prep feature was used to manually trigger the angiographic exam when 311 
contrast medium was seen in the right ventricular outflow tract; the MDCT unit had 312 
an inherent additional delay of 5s to start the diagnostic scan. All MDCTA and MRI 313 
exams resulted in studies of diagnostic image quality. Mild motion artifact was seen 314 
on the MDCTA studies during systole but did not influence the ability to apply 315 
measurements. This was mainly displayed as a mild shift between the acquisition 316 
segments during systole.  317 
Volumetric measurements generated from the awake echocardiograms, MDCTA 318 
and cardiac MRI using anesthetic Protocol A and B are listed in Table 2. There 319 
were no significant differences for the evaluated volumetric variables between 320 
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the two anesthetic protocols when comparing within the individual cross-sectional 321 
modalities (MDCTA and MRI, P > 0.05; Table 2 and 3). Comparing the evaluated 322 
planar variables between the two anesthetic protocols within the individual cross-323 
sectional modalities (MDCTA and MRI) using the paired Wilcoxon signed rank 324 
test, no significant differences were found for any of the variables; P = 0.292 for 325 
LVIDs using MRI and P = 1 for all other variables (Table 3). There was also no 326 
difference between the measurements repeated for the same variable on 327 
different imaging planes (P = 1). The anesthesia protocols were therefore 328 
combined for the following analysis. Evaluation of the difference for the 329 
volumetric variables generated from MDCTA and MRI while combining the 330 
measures for the two different anesthetic episodes per modality and individual as 331 
generated by the Bland-Altman analysis are given in Table 4. The graphical 332 
output is displayed in Figure 8 for the left ventricular variables and Figure 9 for 333 
the right ventricular variables. The bias resulting from the comparison between 334 
MDCTA and MRI when accounting for both measures of each individual per 335 
modality generated in the Bland-Altman analysis is given in Table 5; Figures 10 336 
and 11 show the left ventricular variables and selected further planar 337 
measurements respectively as graphical output. Finally, when determining if the 338 
left ventricular volumetric values generated using the cross-sectional modalities 339 
with anesthetic protocol A and B would be able to predict the comparable 340 
variables generated with echocardiography on the awake dog, significant 341 
agreement was found only for LVEDV using MDCTA and anesthetic protocol B 342 
(P = 0.01). All other modality and anesthesia combinations for LVEDV, LVESV, 343 
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LVSV, LVEF did not agree (P > 0.05) and would not allow for prediction of 344 
measurements generated using echocardiography in the awake animal (Table 2, 345 
Figure 12).  346 
Comparison of the planar variables from the five exams (awake echocardiography 347 
and MDCTA, MRI using Protocol A, B) showed significant differences for the 348 
following variables: IVSs P=0.0006, LVIDd P=0.03, LVIDs P=0.002, FS P=0.0005, 349 
AoDiam P=0.004, LADiam P=0.003, PADiam P=0.0009, LAAoRatio P=0.0421, 350 
AoPARatio P=0.048 (Figure 13 and 14). When testing if the planar measurements 351 
acquired using the cross-sectional imaging modalities with the dogs anesthetized 352 
would be able to predict measurements generated by echocardiography in the 353 
awake dog, no significant agreement was found (P = 1 all variables).  354 
 355 
 356 
Discussion: 357 
In the current study, diagnostic quality cardiac examinations were successfully 358 
acquired in a group of healthy beagle dogs using two different anesthetic protocols 359 
and both 64-MDCTA and 3T MRI. The use of different anesthetic protocols for the 360 
use in cardiac cross-sectional exams has not yet been evaluated; both anesthetic 361 
protocols used in this study were well tolerated and produced comparable results 362 
for the vital variables recorded in the healthy study population.  363 
Heart rate control has been reported essential for image quality for MDCT 364 
acquisitions; high and irregular heart rates will cause motion artifact as the 365 
anatomy of the heart and the intravascular bolus may be depicted at different 366 
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points of the cardiac cycle in the different acquisition segments.32 The target heart 367 
rate of <65 bpm recommended in the human literature for cardiac MDCTA was not 368 
reached consistently using either protocol. Despite this, overall very good image 369 
quality was achieved at the given temporal resolution using a 64-MDCTA unit and 370 
a 0.35s tube rotation time. Mild motion artifact was seen in during systole exams 371 
that was displayed as mild shifting between the acquisition segments, yet this did 372 
not negatively influence the diagnostic quality of the studies and allowed for all 373 
measurements. Further advancement of CT technology using 320 detector row or 374 
dual source units are further increasing the speed of image acquisition and may 375 
lessen the need for lowering the heart rate for cardiac CT exams in the future.57 A 376 
recent study used dual source MDCT for the evaluation of left ventricular volumes 377 
in dogs, and even though no specific comments on image quality were made a 378 
mean heart rate greater than 70 bpm allowed for acquisition of the volumetric 379 
measurements.29  380 
The SSFP MRI sequences were acquired retrospectively EKG-gated during a 381 
breath hold. The arrhythmia rejection feature was turned off during acquisition as 382 
this commonly aborted the scan on the initial dog. The time to repetition (TR) is a 383 
function of the patients heart rate as recorded by the gating software and varied 384 
between 3.3-4.1ms in the exams and resulted in excellent image quality at the 385 
given heart rates.58  386 
Left ventricular systolic function variables investigated in this study were LVEDV, 387 
LVESV, LSV, LVEF and no difference between either anesthetic protocol or either 388 
of the three imaging modalities was identified. This differs from a recent study 389 
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using a similar population of dogs, where the authors report higher end diastolic 390 
volume values generated on cardiac CT exams compared to MRI exams 391 
represented by a linear relationship between the modalities.28 The reason for this 392 
disagreement is not clear but we speculate that this might relate to a systematic 393 
discrepancy in the evaluation of the measurements performed between CT or MRI 394 
versus a true alteration induced by the larger contrast bolus injected for the CT 395 
exam compared to no contrast injected for the MRI exam; alternatively the order 396 
of imaging modalities was not randomized in that study and an effect of anesthetic 397 
duration may have contributed. It is important to verify inclusion of the same portion 398 
of the heart in the analysis by comparison of the systolic to diastolic myocardial 399 
volume mass as calculated by subtraction of endocardial from the epicardial 400 
volumes; this was performed in our study and might have aided to minimize an 401 
effect by modality compared to the report by Sieslack et al.28  402 
In addition, since all dogs also had a low level (~1-2%) of isoflurane added to their 403 
anesthetic protocol in our study, any potential differences in these variables 404 
associated with the two protocols may have been masked by isoflurane since 405 
administration produces dose-dependent cardiovascular depression in dogs.59  406 
Measurement of the myocardial mass is of interest in people in evaluating 407 
hypertrophic cardiomyopathies or the effects of downstream hypertension and is 408 
used as an independent variable in patients with heart disease. It has also been 409 
applied in experimental animal studies for the left and right ventricle.2, 60-63 This 410 
variable has rarely been reported generated using MRI or MDCTA in companion 411 
animals but left myocardial wall thickness is regularly included in 412 
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echocardiographic reporting in companion animals and further evaluation of this 413 
variable might be helpful in companion animal cardiac MRI or MDCTA.26, 31, 64, 65 414 
Inclusion or exclusion of the papillary muscles into the ventricular volume has been 415 
used variably between authors and exclusion of the papillary muscles from the left 416 
ventricular volume will naturally result in small systematic differences in the 417 
quantitative values.60, 62, 66, 67 In echocardiographic exams the papillary muscles 418 
are typically disregarded using Simpson’s rule estimates and by definition in 419 
Teichholz estimates.68 Automated threshold based 3D segmentation methods can 420 
be used to assess ventricular function and will usually exclude the papillary 421 
muscles from the ventricular lumen as the attenuation of intraluminal contrast 422 
medium versus the myocardium is used for threshold settings.66 423 
We aimed to keep the contrast and saline chaser volume low in the MDCT part of 424 
our study to avoid volume overloading of the dogs; ventricular contrast achieved 425 
was adequate to depict the anatomy to semi-automatically outline the endocardial 426 
surfaces of the left and, despite the relatively small contrast volume used, also the 427 
right ventricle. However the ventricular enhancement was at the low end for 428 
recognition using automated threshold settings so these could not be consistently 429 
applied and planar measurements (Simpson method) were therefore performed in 430 
this study using the short axis planes for the left and transverse planes for the right 431 
heart. This is more time consuming for the evaluator and bears potential room for 432 
observer variance; this study used one evaluator to avoid introduction of inter-433 
observer variation. The papillary muscles were consistently included in the 434 
ventricular volume in our study due to institutional preference. Overall the LVEDV 435 
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reported in our study is slightly lower as reported by Sieslack28 whereas the stroke 436 
volumes reported are fairly similar. This may therefore relate to the inclusion of the 437 
papillary muscles but a difference caused by the anesthetic protocols used cannot 438 
be ruled out since they affect the cardiovascular system to differing degrees. 439 
Systolic right ventricular function variables have not been investigated in 440 
companion animals using cross-sectional modalities but this gains progressive 441 
interest for evaluation in people.60, 69 This study showed also no difference 442 
between the two anesthetic protocols as well as imaging modality used for the 443 
assessment of RVEDV, RVESV, RVSV and RVEF and delivers an initial reference.  444 
Overall, no difference was found for any of the evaluated planar variables using 445 
either anesthetic protocol within the modalities, MDCTA or MRI. This would make 446 
the use of the protocols interchangeable for evaluation of these variables within 447 
each modality. There was also a low bias in comparing MDCTA and MRI for all 448 
variables when the anesthesia protocols were combined. However, because our 449 
study was performed in healthy dogs, we cannot extrapolate our data to other 450 
species or to patients with cardiovascular diseases or abnormalities. 451 
Placement of the measurements was overall easily performed, only over the 452 
caudal aspect of the left atrium mild flow-artifact from the pulmonary venous inflow 453 
made the delineation of the caudal atrial border difficult at times. However, the bias 454 
between the measurements acquired on MDCTA and MRI was only 0.3cm for this 455 
variable; though this should be considered as a possible disadvantage when using 456 
MRI to evaluate the caudal left atrial border.  457 
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As expected, the MRI and CT variables acquired using anesthesia protocols A and 458 
B produced different values to those acquired in the awake animals using 459 
echocardiography. Left end diastolic volumes were higher, end systolic volumes 460 
were lower; left ventricular stroke volume and ejection fractions were higher using 461 
echocardiography in the awake animals compared to any of the anesthesia 462 
modality combinations, even though there was overlap. These findings are 463 
consistent with those found in previous studies in isoflurane-anesthetized dogs.70 464 
A recent study compared echocardiographic measurement of the left ventricular 465 
volume using the Teicholz and modified Simpson method to left ventricular 466 
volumes acquired using dual source CT and applying the Simpson method in 467 
seven propofol/isoflourane anesthetized dogs using medetomedine as 468 
premedication. In this study the left ventricular volumes using the modified 469 
Simpson method in echocardiography underestimated the volume both compared 470 
to echocardiographic measurement using the Teichholz method and 471 
measurements from the dual source CT studies using the modified Simpson 472 
method29. In a different study using ten propofol/isoflourane anesthetized dogs 473 
induced with diazepam and levomethadone showed a high correlation of the mean 474 
values for EDV and ESV measured from MDCT or echocardiographic exams, 475 
using the Simpson method as preferred calculation of the volumes.23, 27 Another 476 
study evaluated ten dogs using a non-specified anesthetic protocol for assessment 477 
of left ventricular volumes using three-dimensional echocardiography and 478 
magnetic resonance imaging did not find significant differences for EDV, ESV, and 479 
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EF between the two modalities, but differences were found comparing to one or 480 
two dimensional echocardiographic measurements.27 481 
The IVSs measurement was larger when evaluated using echocardiography in the 482 
awake dogs, possibly indicating higher contractility in the awake compared to 483 
anesthetized dog as shown previous reports in isoflurane-anesthetized dogs;70 this 484 
effect was present but weaker for LVPWs. Similarly, the fractional shortening was 485 
greater and LVIDs was lower in the awake dogs compared to either of our 486 
anesthesia protocols, most likely due to the background of isoflurane in all dogs.70 487 
The aortic and pulmonary artery diameter was larger in the awake versus 488 
anesthetized patients. Although previous reports have reported smaller aortic and 489 
pulmonic diameters in isoflurane-anesthetized dogs,41, 71 others have shown no 490 
change.70 Even though blood pressure measurements were not acquired on the 491 
awake dogs, a reduction in systemic and pulmonary diameter is consistent with 492 
lower blood pressures associated with isoflurane anesthesia even though a 493 
modality specific alteration of acquisition of the variable cannot be fully ruled out.  494 
The left atrial diameter was lower evaluated in the awake dogs compared to any 495 
of the anesthesia protocol–modality combinations. Mildly reduced cardiac 496 
contractility in the anesthetized dogs might explain this finding. Based on the 497 
difference in these measurements the LAAo ratio was additionally altered in the 498 
anesthetized animals; for the AoPA ratio there was greater overlap but also no 499 
predictive value for echocardiography was generated.  500 
A previous study used seven isoflourane anesthetized normal beagles to compare 501 
anatomical measurements acquired using dual source CT to echocardiographic 502 
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measurements and found overall good agreement except for the values of the 503 
interventricular wall and left ventricular posterior wall thickness in end diastole.41 504 
The authors of this study speculate that interference of anatomical structures such 505 
as the papillary muscles or chorda tendinae in combination with lower far-field 506 
image quality in echocardiography compared to the high quality of the dual source 507 
CT images may be causative for this discrepancy. As clinical patients are unlikely 508 
to undergo an anesthetized echocardiogram before cross-sectional imaging a 509 
possible discrepancy of the values as described in our study may be considered. 510 
Alternatively evaluation of the cross-sectional measurements in the anesthetized 511 
animal compared to awake echocardiography in a larger patient group may show 512 
trends that may allow for prediction between the modalities in the future. 513 
 514 
The main limitation of this study includes the low number of study subjects used; 515 
ideally a larger and more varied study population representing different dog 516 
breeds, sizes and chest morphologies might have been included. MRI studies took 517 
markedly longer to acquire than the MDCTA studies; availability of the respective 518 
modalities as well as the study question may determine the choice of modality for 519 
companion animal patients in the future, as a low bias was present between the 520 
modalities in our study. Both modalities resulted in overall very good and 521 
diagnostic image quality.  522 
 523 
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Tables 796 
Table 1: Summary of the Vital Variables Recorded during MDCTA and MRI Exams using Protocol A (Midazolam/Fentanyl) 797 
and Protocol B (Dexmedetomedine) in ten dogs. *  798 
  Protocol A Protocol B 
  Median 
(min-max) 
Median 
(min-max) 
CT    
 heart rate (bpm) 81.6  
(68.6-96) 
73.3  
(62.7-102.6) 
 mean blood pressure (mmHg) 65.0  
(48.8-74.0) 
65.3  
(57-102.8)* 
 systolic arterial pressure (mmHg) 92.5  
(74.3-100.4) 
92.7  
(81.0-129.8) 
 diastolic arterial pressure (mmHg) 37.6  
(28.2-47.2) 
44.2  
(31.8-75.8)* 
 32 
 CO2 (%) 39.7  
(34.7-46.7) 
35.5  
(34.7-45.0) 
MRI    
 heart rate (bpm) 76.8  
(66-98.6) 
71 
(64.4-118.8) 
 mean blood pressure (mmHg) 60.5  
(48.4-68.9) 
75.3 
(66.1-94.0) 
 systolic arterial pressure (mmHg) 89.1 
(75.3-95.6) 
101.9  
(91.7-117.6) 
 diastolic arterial pressure (mmHg) 36.2  
(29.2-43.4) 
51.9 
(30.9-72.5) 
 CO2 (%) 37.5 
(34.3-45.8). 
34.1 
(30.6-37.0) 
799 
 33 
*When comparing Protocol A and B there was significant difference for the mean (P = 0.012), diastolic arterial (P = 0.033) 800 
and marginal difference for the systolic arterial blood pressure (P = 0.052). For the remaining variables no difference was 801 
found (heart rate, CO2; P = 1). 802 
 803 
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Table 2: Volumetric Measurements Generated from the Echocardiograms Obtained in the Ten Dogs Awake as well as the 805 
cardiac 64-MDCTA and 3T MRI Exams Using Anesthetic Protocol A and Protocol B.  806 
 807 
Modality Echocardiography MDCTA MRI 
Anesthetic protocol Awake Protocol A Protocol B Protocol A Protocol B 
  Median 
(min-max) 
Median 
(min-max) 
Median 
(min-max) 
Median 
(min-max) 
LVEDV (ml) 42.5 
(29.0-56.0)* 
34.7  
(26.9-41.1) 
37.8 
(26.6-43.2)† 
38.1 
(30.0-45.2) 
36.2  
(26.7-45.1) 
LVESV  (ml) 15.5 
(8.0-21.0)* 
16.9 
(8.8-25.2) 
17.0 
(14.8-26.8) 
17.8 
(13.0-25.8) 
18.75 
(12.9-25.8) 
LSV (ml) 25.5 
(19.0-39.0)* 
17.2 
(15.2-25.1) 
18.2 
(11.7-22.5) 
19.5 
(15.4-22.1) 
17.6 
(9.9-26.0) 
LVEF (%) 62.0  
(51.0-79.0)* 
52.5  
(37.7-71.1) 
47.3 
(36.2-60.3) 
52.8 
(42.9-59.7) 
43.9 
(33.8-64.5) 
 35 
LVmassD (mg) 60.2 
(30.7-68.4) 
39.4 
(27.7-46.4) 
38.6 
(28.2-44.1) 
39.4 
(27.5-45.7) 
39.4 
(26.7-48.7) 
LVmass (mg) NA 39.1 
(26.9-47.2) 
37.0 
(28.5-44.8) 
39.1  
(28.7-47.3) 
40.1 
(27.8-43.3) 
RVEDV (ml) NA 36.8 
(29.2-41.1) 
35.6 
(27.2-44.4) 
42.7 
(32.2-50.9) 
40.2 
(30.1-50.5) 
RVESV (ml) NA 22.4 
(14.6-28.7) 
21.9 
(14.9-32.5) 
22.5 
(15.5-29.1) 
25.4 
(15.1-30.6) 
RVSV (ml) NA 14.5 
(8.2-20.3) 
12.2 
(7.3-21.3) 
18.5 
(14.6-25.3) 
16.2 
(8.1-22.7) 
RVEF (%) NA 40.0 
(22.3-55.1) 
37.4 
(23.6-48.2) 
45.2 
(38.6-58.2) 
43.3 
(23.6-50.0) 
808 
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*Simpson’s Method, †P-value for comparison of echocardiography and MDCT for LVEDV 809 
= 0.01, all other P-values are greater than 0.05 or N/A.  810 
 811 
LVEDV = left ventricular end diastolic volume; LVESV = left ventricular end systolic 812 
volume; LSV = left ventricular stroke volume; LVEF = left ventricular ejection fraction; 813 
LVmassD = diastolic left ventricular myocardial mass; LVmassS = systolic left ventricular 814 
myocardial mass; RVEDV = right ventricular end diastolic volume; RVESV = right 815 
ventricular end systolic volume; RVSV = right ventricular stroke volume; RVEF = right 816 
ventricular ejection fraction 817 
 818 
 819 
 820 
 821 
 822 
 823 
 824 
 825 
 826 
 827 
 828 
 829 
 830 
 831 
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Table 3: Planar Measurements Generated from the Echocardiographic Exam Obtained 832 
in the Ten Dogs Awake as well as Cardiac 64-MDCTA and 3T MRI Exams Using Protocol 833 
A and B.*   834 
 835 
 836 
 837 
 838 
 839 
 840 
 841 
 842 
 843 
 844 
 845 
 846 
 847 
 848 
 849 
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Modality Echo CTA MRI 
Anesthetic protocol Awake 
Median 
(min-max) 
Protocol A 
Median 
(min-max) 
Protocol B 
Median 
(min-max) 
Protocol A 
Median 
(min-max) 
Protocol B 
Median 
(min-max) 
 
IVSd (cm) 0.76 
(0.66-0.88) 
0.73  
(0.52-0.79) 
0.74 
(0.49-0.82) 
0.79 
(0.66-1.02) 
0.77 
(0.59-0.98) 
IVSs (cm) 1.06  
(0.95-1.2) 
0.8 
(0.58-0.95) 
0.85 
(0.61-0.96) 
0.94 
(0.66-1.47) 
0.77 
(0.54-1.04) 
LVIDd (cm) 3.25 
(2.79-3.63) 
2.97  
(2.69-3.31) 
2.98 
(2.78-3.35) 
3.19 
(2.97-3.45) 
3.41 
(2.84-3.63) 
LIVDs (cm)  2.15  
(1.67-2.45) 
2.56 
(2.23-2.76) 
2.64 
(2.35-3.03) 
2.6 
(2.04-2.96) 
2.67 
(2.23-3.07) 
LVPWd (cm) 0.68 
(0.53-0.79) 
0.75 
(0.6-1.0) 
0.75 
(0.66-0.84) 
0.76 
(0.52-0.94) 
0.73 
(0.7-0.94) 
LVPWs (cm) 1.03  
(0.85-1.17) 
1.0 
(0.72-1.23) 
0.9 
(0.72-1.0) 
1.04 
(0.46-1.25) 
0.92 
(0.65-1.22) 
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FS (%) 33.5 
(26.0-41.0) 
13.11 
(6.88-25.22) 
12.08 
(3.53-20.22) 
21.5 
(12.11-32.44) 
16.81 
(11.85-29.53) 
LA diam 3ch (cm) 2.21  
(1.92-2.49) 
2.93 
(2.62-3.24) 
2.99 
(2.63-3.34) 
2.8 
(2.10-2.92) 
2.72 
(2.41-2.99) 
Mitral annulus 3ch (mm)  NA 2.01 
(1.82-2.08) 
1.93 
(1.5-2.2) 
2.02 
(1.71-2.34) 
1.94 
(1.83-2.20) 
Ao annulus 3ch (%) 1.71  
(1.55-
1.97)* 
1.3 
(0.99-1.37) 
1.3 
(1.09-1.38) 
1.17 
(0.94-1.47) 
1.18 
(1.04-1.34) 
LA/Ao ratio 1.27  
(1.18-1.49) 
2.34 
(1.97-3.05) 
2.34  
(1.97-3.05) 
2.41 
(1.93-3.04) 
2.35 
(1.8-2.64) 
Mitral annulus diam 4ch (cm) NA 2.4 
(2.12-2.58) 
2.4 
(2.19-2.69) 
2.13 
(1.69-2.23) 
2.04 
(1.8-2.34) 
prox Ao (cm) NA 1.27 
(1.14-1.52) 
1.28 
(1.08-1.51) 
1.28 
(1.07-1.6) 
1.32 
(1.18-1.56) 
MPA (cm) 1.6 
(1.5-1.8) † 
1.39 
(1.21-1.56) 
1.33 
(0.92-1.56) 
1.23 
(1.11-1.24) 
1.3 
(1.12-1.56) 
 40 
Ao/PA ratio 0.99  
(0.86-1.31) 
0.96  
(0.82-1.04) 
0.96 
(0.8-1.48) 
1.03 
(0.96-1.22) 
1.09 
(0.98-1.19) 
850 
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IVSd = diastolic interventricular septal thickness; IVSs = systolic interventricular 851 
septal thickness; LVIDd = diastolic left ventricular internal diameter, measured 852 
just proximal to the papillary muscles; LVIDs = systolic left ventricular internal 853 
diameter, measured just proximal to the papillary muscles; LVPWd = diastolic left 854 
ventricular posterior wall thickness; LVPWs = systolic left ventricular posterior 855 
wall thickness; FS% = percent fractional shortening; LA diam 3ch = left atrial 856 
diameter measured on three chamber view; Mitral annulus 3ch = mitral annulus 857 
measured on approximated three-chamber view; Ao annulus 3ch = aortic 858 
annulus measured on three-chamber view; LA/Ao ratio = Left atrium to aorta 859 
ratio; Mitral annulus 4ch = mitral annulus measured on four-chamber view; prox 860 
Ao = Proximal aorta measured on transverse plane; MPA = main pulmonary 861 
artery transverse plane; Ao/PA ratio = Aorta to pulmonary artery ratio. *Aortic 862 
annulus measured in right parasternal view for the left ventricular outflow tract on 863 
echocardiography; † MPA measured in right parasternal short axis view on 864 
echocardiography 865 
‡No statistically significant differences were found between the anesthetic 866 
protocols within the cross-sectional modalities using the paired Wilcoxon rank 867 
sum test (P = 0.292 for LVIDs using MRI; P = 1 for all other variables). The 868 
cross-sectionally acquired measurements did not allow for prediction of the 869 
values generated using echocardiography in the awake dogs (P = 1 for all 870 
variables). 871 
 872 
 873 
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 874 
 875 
 876 
 877 
 878 
 879 
 880 
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Table 4: Results of the Bland-Altman Analysis Characterizing the Differences for 881 
the Volumetric Measurements Between the 64-MDCTA and 3T MRI Exams (MRI 882 
minus CT) When Combining the Results of the two Anesthetic Protocols per 883 
Modality and Individual.  884 
 885 
Volumetric 
cardiac variable 
LLOA Bias ULOA 
LVEDV (ml) -5.43 1.42 8.27 
LVESV (ml) -4.28 1.37 7.02 
LSV (ml) -6.84 0.05 6.94 
LVEF (%) -17.45 -2.11 13.24 
LVmassD (mg) -6.51 2.05 10.62 
LVmassS (mg) -5.33 1.62 8.58 
RVEDV (ml) -6.87 5.08 17.04 
RVESV (ml) -7.88 0.89 9.66 
RVSV (ml) -3.63 4.19 12.02 
RVEF (%) -9.54 5.51 20.57 
LLOA = 95% lower level of agreement; ULOA = 95% upper level of agreement; 886 
LVEDV = left ventricular end diastolic volume; LVESV = left ventricular end systolic 887 
volume; LSV = left ventricular stroke volume; LVEF = left ventricular ejection 888 
fraction; LVmassD = diastolic left ventricular myocardial mass; LVmassS = systolic 889 
left ventricular myocardial mass; RVEDV = right ventricular end diastolic volume; 890 
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RVESV = right ventricular end systolic volume; RVSV = right ventricular stroke 891 
volume; RVEF = right ventricular ejection fraction. 892 
 893 
 894 
 895 
 896 
 897 
 898 
 899 
 900 
 901 
 902 
 903 
 904 
 905 
 906 
 907 
 908 
 909 
 910 
 911 
 912 
 913 
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Table 5: Bias and 95% Upper (ULOA) and Lower Level of Agreement (ULOA) 914 
Generated by the Comparison of the Planar Variables Acquired using 64-MDCTA 915 
and 3T MRI (MRI minus CT) using the Bland-Altman Analysis are Reported.  916 
 917 
Planar variable LLOA Bias ULOA 
IVSd (cm) - 0.19 0.08 0.35 
IVSs (cm) - 0.29 0.09 0.46 
LVIDd (cm) - 0.15 0.21 0.56 
LIVDs (cm) - 0.49 - 0.01 0.47 
LVPWd (cm) - 0.21 - 0.01 0.18 
LVPWs  (cm) - 0.42 0.0 0.42 
FS (%) - 9.29 5.94 21.18 
LA diam (cm) - 0.37 - 0.3 0.18 
Mitral annulus 3ch (cm) - 0.31 0.04 0.38 
Ao annulus 3ch (cm) - 0.37 - 0.1 0.18 
LA/Ao ratio - 0.88 - 0.01 0.86 
Mitral annulus 4ch (cm) - 0.8 - 0.35 0.09 
prox Ao (cm) - 0.16 0.02 0.21 
MPA (cm) - 0.45 - 0.09 0.27 
Ao/PA ratio (cm) - 0.19 0.08 0.65 
Mitral annulus: 3ch vs 4ch (cm) - 0.29 0.27 0.83 
 918 
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Overall good agreement was found between the modalities when combining the 919 
anesthetic protocols per modality and individual.  920 
 921 
LLOA = lower level of agreement; ULOA = upper level of agreement; IVSd = 922 
diastolic interventricular septal thickness; IVSs = systolic interventricular septal 923 
thickness; LVIDd = diastolic left ventricular internal diameter, measured just 924 
proximal to the papillary muscles; LVIDs = systolic left ventricular internal 925 
diameter, measured just proximal to the papillary muscles; LVPWd = diastolic left 926 
ventricular posterior wall thickness; LVPWs = systolic left ventricular posterior 927 
wall thickness; FS% = percent fractional shortening; LA diam 3ch = left atrial 928 
diameter measured on three chamber view; Mitral annulus 3ch = mitral annulus 929 
measured on approximated three-chamber view; Ao annulus 3ch = aortic 930 
annulus measured on three-chamber view; LA/Ao ratio = Left atrium to aorta 931 
ratio; Mitral annulus 4ch = mitral annulus measured on four-chamber view; prox 932 
Ao = Proximal aorta measured on transverse plane; MPA = main pulmonary 933 
artery transverse plane; Ao/PA ratio = Aorta to pulmonary artery ratio 934 
 935 
 936 
 937 
 938 
 939 
 940 
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Figures 942 
 943 
Figure1: Using the short axis plane the epicardial (yellow line, arrow head) and 944 
endocardial (turquoise line, arrow) surface of the left ventricle (LV) were outlined 945 
on all images including the left ventricle to calculate the volumetric variables; each 946 
at the end diastolic (A, C) and end systolic (B, D) phase for MDCTA and MRI 947 
respectively; exemplary views are given at the level of the papillary muscles. 948 
Papillary muscles (*) were included in the left ventricular volume. RV = right 949 
ventricle.  950 
 951 
 48 
 952 
Figure 2: Using transverse plane images the endocardial surface (turquoise line) 953 
of the right ventricle (RV) was outlined on all images including the right ventricle, 954 
where the tricuspid and pulmonic annulus marked the borders of the ventricular 955 
volume included. This was performed at the end diastolic (A, C) and end systolic 956 
(B, D) phase for MDCTA and MRI respectively; exemplary views are given at the 957 
level of the right ventricular outflow tract. MPA = main pulmonary artery. 958 
 49 
 959 
Figure 3: Short axis view of the left ventricle end diastolic (A, C) and end systolic 960 
(B, D) using MDCTA and MRI respectively, showing the measurement of IVS 961 
(interventricular septum) and LVPW (left ventricular posterior wall) thickness and 962 
LVID (left ventricular internal diameter) using double-headed arrows. Single-963 
headed arrow showing mild motion artifact in end systole, this did not interfere with 964 
placement of measurements. RV = Right ventricle.  965 
 50 
 966 
Figure 4: End systolic three-chamber view generated using MDCTA (A) and MRI 967 
(B) respectively for measurement of the left atrial (light blue line) and aortic annulus 968 
(dark blue line) diameter. Mitral valves (green arrows) are closed, aortic valves are 969 
open. There is mild flow artefact on the MRI image over the caudal aspect of the 970 
left atrium (yellow arrow) arising from inflow from the pulmonary veins and mild 971 
motion artefact over the caudal aspect of the left ventricle (yellow arrows) over the 972 
left ventricle on the MDCTA image. LA = left atrium; LV = left ventricle; RV = right 973 
ventricle; Ao = aorta. 974 
  975 
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 976 
Figure 5: End diastolic three-chamber view generated using MDCTA (A) and MRI 977 
(B) respectively for measurement of the mitral annulus diameter measurement 978 
(light blue and yellow respectively). Mitral valves are open (green arrow). LA = left 979 
atrium; LV = left ventricle; RV = right ventricle; Ao = aorta. 980 
  981 
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 982 
Figure 6: Approximate four-chamber view using MDCTA (A) and MRI (B) for repeat 983 
measurement of the mitral annulus diameter (light blue line) at end diastole. LA = 984 
left atrium; LV = left ventricle; RV = right ventricle. 985 
  986 
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 987 
Figure 7: Transverse plane view using MDCTA (A) and MRI (B) respectively for 988 
measurement of the diameter of the proximal aorta (Ao, blue line) and the main 989 
pulmonary artery (MPA, yellow line). RPA = right pulmonary artery; LPA = left 990 
pulmonary artery; RV = right ventricle. 991 
 54 
 992 
Figure 8: Graphical display of the Bland-Altman analysis comparing the left 993 
ventricular volumetric measurements generated using 64-MDCTA (CT) versus 3T-994 
MRI (MR) while combining the measures for the two different anesthetic episodes 995 
per modality. The bias is given by the central horizontal line, the 95% lower and 996 
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upper level of agreement are indicated by the above and below horizontal lines. 997 
LVEDV: Left Ventricular End Diastolic Volume (ml); Left Ventricular End Systolic 998 
Volume (ml); LVmassD: Left Ventricular Myocardial Mass at Diastole (mg); 999 
LVmassS: Left Ventricular Myocardial Mass at Systole (mg); LVSV: Left 1000 
Ventricular Stroke Volume (ml); LVEF: Left Ventricular Ejection Fraction (ml). Dex 1001 
= Anesthetic Protocol B; MidFent = Anesthetic Protocol A. 1002 
 56 
 1003 
Figure 9: Graphical display of the Bland-Altman analysis comparing the right 1004 
ventricular volumetric measurements generated using MDCTA versus MRI while 1005 
combining the measures for the two different anesthetic episodes per modality. 1006 
The bias is given by the center horizontal line, the 95% lower and upper level of 1007 
agreement are indicated by the above and below horizontal lines. RVEDV: Right 1008 
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Ventricular End Diastolic Volume (ml); RVESV: Right Ventricular End Systolic 1009 
Volume (ml); RVSV: Right Ventricular Stroke Volume (ml); RVEF: Right Ventricular 1010 
Ejection Fraction (ml). Dex=Anesthetic Protocol B; MidFent=Anesthetic Protocol 1011 
A. 1012 
  1013 
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 1014 
Figure 10: Graphical display of the Bland-Altman analysis comparing the planar 1015 
left ventricular measurement generated using MDCTA (CT) versus MRI (MR) when 1016 
combining the measures for the two different anesthetic episodes per modality. 1017 
 59 
The bias is shown by the central horizontal line, the 95% lower and upper levels of 1018 
agreement are depicted as the horizontal lines above and below.  1019 
IVSd: interventricular septum thickness at diastole (cm); IVSs: interventricular 1020 
septum thickness at systole (cm); LVIDd: left ventricular internal diameter at 1021 
diastole (cm); left ventricular internal diameter at systole (cm); LVPWd: left 1022 
ventricular diameter at diastole (cm); LVPWs: left ventricular diameter at systole 1023 
(cm); fractShort: fractional shortening (%) 1024 
  1025 
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 1026 
Figure 11: Graphical display of the Bland-Altman analysis comparing the LA/Ao-1027 
Ratio (left atrium (generated from three chamber view) to aorta ratio) and Ao/PA-1028 
Ratio (aorta to pulmonary artery ratio) generated from the planar measurements 1029 
using MDCTA (CT) versus MRI (MR) when combining the measurements for the 1030 
two different anesthetic episodes per modality. The bias is shown by the central 1031 
horizontal line, the 95% lower and upper levels of agreement are depicted as the 1032 
horizontal lines above and below. 1033 
  1034 
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 1035 
Figure 12: Graphical Display using Box-Pots to Compare the Volumetric 1036 
Measurements acquired using the Anesthetic Protocol and Cross-sectional 1037 
Modality Combinations to the Echocardiographic Results Gathered from the 1038 
 62 
Awake Animals. Adjusted P-Values for all five exams (awake echocardiogram, 1039 
anesthesia and MDCT, MRI using Protocol A, B)  are given below the plots. Only 1040 
LVEDV using MDCTA and anesthetic protocol B (P = 0.01) was able to allow for 1041 
measurements generated using awake echocardiogram.  LVEDV (ml): Left 1042 
Ventricular End Diastolic Volume; LVESV (ml): Left Ventricular End Systolic 1043 
Volume; LVSV (ml): Left Ventricular Stroke Volume; LVEF (%): Left Ventricular 1044 
Ejection Fraction 1045 
AwakeEcho = Echocardiogram performed on the awake dogs; DexCT = MDCTA 1046 
using Anesthetic Protocol B; DexMR = MRI using Anesthetic Protocol B; 1047 
MidFentCT = MDCTA using Anesthetic Protocol A; MidFentMR = MRI using 1048 
Anesthetic Protocol A. Line segments join observations obtained from the same 1049 
dog as imaging and anesthesia protocols vary. 1050 
  1051 
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 1052 
Figure 13: Graphical display using box-plots to compare left ventricular planar 1053 
measurements generated using the four anesthetic protocol and modality 1054 
 64 
combinations to the echocardiographic results gathered from the awake animals. 1055 
No significant differences were found for any of the variables comparing the 1056 
anesthesia protocols within each modality using paired Wilcoxon testing.  Adjusted 1057 
P-values comparing all five exams (awake echocardiogram, anesthesia and 1058 
MDCT, MRI using Protocol A, B) are given below the plots. Prediction of 1059 
echocardiographic measurements using the cross-sectional modalities was not 1060 
possible (P =1).  1061 
IVSd (cm): interventricular septal thickness at diastole; IVSs (cm): interventricular 1062 
septal thickness at systole; LVIDd (cm): left ventricular internal diameter at 1063 
diastole. Using protocol A and 64-MDCTA this was the only variable allowing for 1064 
predictions of the echocardiographic measurement in the awake dog; LIVDs (cm): 1065 
left ventricular internal diameter at systole; LVPWd (cm): left ventricular posterior 1066 
wall at diastole; LVPWs (cm): left ventricular posterior wall at systole; FractShort 1067 
(%): fractional shortening.  1068 
AwakeEcho = echocardiogram performed on the awake dogs; DexCT = MDCTA 1069 
using anesthetic protocol B; DexMR = MRI using anesthetic protocol B; MidFentCT 1070 
= MDCTA using anesthetic protocol A; MidFentMR = MRI using anesthetic protocol 1071 
A. Line segments join observations obtained from the same dog as imaging and 1072 
anesthesia protocols vary. 1073 
  1074 
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 1075 
Figure 14: Graphical display using Box-Pots showing comparison of selected 1076 
planar measurements generated using the four anesthetic protocol and modality 1077 
combinations to the echocardiographic results gathered from the awake animals. 1078 
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There were no significant differences were found for any of the variables 1079 
comparing the anesthesia protocols within each modality using paired Wilcoxon 1080 
testing.  Adjusted P-values comparing all five exams (awake anesthesia and 1081 
MDCT, MRI using Protocol A, B) are given below the plots. Prediction of 1082 
echocardiographic measurements using the cross-sectional modalities was not 1083 
possible (P =1).  1084 
AoDiam3 (cm): Aortic diameter generated on the three chamber view using the 1085 
cross-sectional modalities; LaDiam3 (cm): left atrial diameter measured on three 1086 
chamber view using the cross-sectional modalities; PADiam (cm): pulmonary 1087 
artery diameter; LaAODiam (cm): left atrium (measured on three chamber view) to 1088 
aorta ratio; AoPADiam (cm): aorta to pulmonary artery ratio 1089 
AwakeEcho = echocardiogram performed on the awake dogs; DexCT = MDCTA 1090 
using anesthetic protocol B; DexMR = MRI using anesthetic protocol B; MidFentCT 1091 
= MDCTA using anesthetic protocol A; MidFentMR = MRI using anesthetic protocol 1092 
A. Line segments join observations obtained from the same dog as imaging and 1093 
anesthesia protocols vary. 1094 
 1095 
